Cost-effectiveness of ribavirin interferon alfa-2B after interferon relapse in chronic hepatitis C.

被引：0
|
作者：
Wong, JB
Davis, GL
Pauker, SG
机构：
[1] Tufts New England Med Ctr, Div Clin Decis Making, Boston, MA USA
[2] Univ Florida, Dept Med, Sect Hepatobiliary Dis, Gainesville, FL USA
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1713
引用
收藏
页码：591A / 591A
页数：1
相关论文
共 50 条
  • [31] Neurocognitive changes in patients with chronic hepatitis C receiving interferon alfa-2b and ribavirin
    Kraus, MR
    Schaefer, A
    Scheurlen, M
    GASTROENTEROLOGY, 2004, 126 (04) : A720 - A721
  • [32] Cost-effectiveness analysis of interferon α-2b with ribavirin for chronic hepatitis C infection
    Malone, DC
    FORMULARY, 2000, 35 (08) : 681 - +
  • [33] Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b
    Molloy, PJ
    Azzouz, M
    VanThiel, DH
    AMERICAN FAMILY PHYSICIAN, 1996, 54 (05) : 1598 - 1602
  • [34] Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy
    Lo Iacono, O
    Castro, A
    Diago, M
    Moreno, JA
    Fernandez-Bermejo, M
    Vega, P
    García, V
    Carbonell, P
    Sanz, P
    Borque, MJ
    García-Buey, L
    García-Monzón, C
    Pedreira, J
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (04) : 463 - 469
  • [35] Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C
    Jen, JF
    Glue, P
    Ezzet, F
    Chung, C
    Gupta, SK
    Jacobs, S
    Hajian, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (06) : 407 - 421
  • [36] The cost-effectiveness of peginterferon alfa-2a (40kd) (PEGASYS) plus ribavirin (COPEGUS) vs. interferon alfa-2b plus ribavirin for chronic hepatitis C (CHC)
    Sullivan, SD
    Green, J
    Patel, KK
    Craxi, A
    Alberti, A
    Giuliani, G
    De Carli, C
    VALUE IN HEALTH, 2003, 6 (03) : 262 - 263
  • [37] Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C : the PegIntrust Study
    Van Vlierberghe, H.
    Adler, M.
    Bastens, B.
    Colle, I.
    Delwaide, J.
    Henrion, J.
    Horsmans, Y.
    Michielsen, P.
    Golstein, P.
    Mulkays, J. -P.
    Van Steenbergen, W.
    Yap, P.
    Nevens, F.
    Denys, A. M.
    Brasseur, J. -P.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2010, 73 (01) : 5 - 11
  • [38] Long-term response to interferon alfa-2b in chronic hepatitis C.
    Kuziemski, A
    Topczewska-Staubach, E
    Pawlowska, M
    Olczak, A
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 428 - 428
  • [39] Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C
    Davis, GL
    SEMINARS IN LIVER DISEASE, 1999, 19 : 49 - 55
  • [40] Recombinant interferon alfa-2B treatment for chronic hepatitis C. Multicenter study
    Feher, J
    Lengyel, G
    Dalmi, L
    David, K
    Gervain, J
    Gogl, A
    Lonovics, J
    Ozsvar, Z
    Par, A
    Schneider, F
    Tulassay, Z
    HEPATOLOGY, 1996, 23 (01) : P121 - P121
12345